In all dues respect I don't agree with the no in between scenario-that stock will necesssarily be at $20 or bankrupt;that is quite presumptuous.
Who is anyone to say that stock can't go gradually up to say $.50,$1.00 or $2.00, find its niche and just float in a range from say $.50, $.75 $1.00 or less to $2.00 for a long time?
No one has any clue what will happen with this stock, the competition and the stem cell industry as a whole.
I have plenty of shares myself and am fairly optimistic, but in all reality I think $20 is a pipe dream at this point no matter what time frame is considered;$.50 or a $1.00 seems much more reasonable when all factors and variables are considered.
In all honesty, if someone offered me $.50 today for all my shares and it was somehow stipulated that if I accepted the offer, I could NEVER buy back any shares of this company in my lifetime no matter what happened to the company and the stock, I would take the $.50 in a heartbeat and move on;I would have a VERY nifty profit and quite satisfied.
News 
Market Data 
Discover 
AI
